165 related articles for article (PubMed ID: 14709953)
21. Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
Jazayeri S; Tehrani-Doost M; Keshavarz SA; Hosseini M; Djazayery A; Amini H; Jalali M; Peet M
Aust N Z J Psychiatry; 2008 Mar; 42(3):192-8. PubMed ID: 18247193
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
23. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.
Jha A; Weintraub A; Allshouse A; Morey C; Cusick C; Kittelson J; Harrison-Felix C; Whiteneck G; Gerber D
J Head Trauma Rehabil; 2008; 23(1):52-63. PubMed ID: 18219235
[TBL] [Abstract][Full Text] [Related]
25. Absence of mood switch with and tolerance to modafinil: a replication study from a large private practice.
Nasr S; Wendt B; Steiner K
J Affect Disord; 2006 Oct; 95(1-3):111-4. PubMed ID: 16737742
[TBL] [Abstract][Full Text] [Related]
26. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
[TBL] [Abstract][Full Text] [Related]
27. Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression.
Baune BT; Caliskan S; Todder D
Hum Psychopharmacol; 2007 Jan; 22(1):1-9. PubMed ID: 17191266
[TBL] [Abstract][Full Text] [Related]
28. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
Fava M; Thase ME; DeBattista C
J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
[TBL] [Abstract][Full Text] [Related]
29. Modafinil use in patients with a primary psychiatric illness.
Black W; Hoey P; Mayze T
Aust N Z J Psychiatry; 2010 Jun; 44(6):583-4. PubMed ID: 20482418
[No Abstract] [Full Text] [Related]
30. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.
Chan KM; Strohschein FJ; Rydz D; Allidina A; Shuaib A; Westbury CF
Muscle Nerve; 2006 Jan; 33(1):138-41. PubMed ID: 16175627
[TBL] [Abstract][Full Text] [Related]
31. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.
Schmidt PJ; Daly RC; Bloch M; Smith MJ; Danaceau MA; St Clair LS; Murphy JH; Haq N; Rubinow DR
Arch Gen Psychiatry; 2005 Feb; 62(2):154-62. PubMed ID: 15699292
[TBL] [Abstract][Full Text] [Related]
32. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
Frye MA; Grunze H; Suppes T; McElroy SL; Keck PE; Walden J; Leverich GS; Altshuler LL; Nakelsky S; Hwang S; Mintz J; Post RM
Am J Psychiatry; 2007 Aug; 164(8):1242-9. PubMed ID: 17671288
[TBL] [Abstract][Full Text] [Related]
33. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Thase ME; Fava M; DeBattista C; Arora S; Hughes RJ
CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686
[TBL] [Abstract][Full Text] [Related]
34. Modafinil for the treatment of fatigue in lung cancer: a pilot study.
Spathis A; Dhillan R; Booden D; Forbes K; Vrotsou K; Fife K
Palliat Med; 2009 Jun; 23(4):325-31. PubMed ID: 19270033
[TBL] [Abstract][Full Text] [Related]
35. Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury.
Kaiser PR; Valko PO; Werth E; Thomann J; Meier J; Stocker R; Bassetti CL; Baumann CR
Neurology; 2010 Nov; 75(20):1780-5. PubMed ID: 21079179
[TBL] [Abstract][Full Text] [Related]
36. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
Ninan PT; Hassman HA; Glass SJ; McManus FC
J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
[TBL] [Abstract][Full Text] [Related]
37. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
38. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome.
Randall DC; Cafferty FH; Shneerson JM; Smith IE; Llewelyn MB; File SE
J Psychopharmacol; 2005 Nov; 19(6):647-60. PubMed ID: 16272188
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder.
Sato Y; Yasui-Furukori N; Nakagami T; Saito M; Kaneko S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):416-8. PubMed ID: 19166896
[TBL] [Abstract][Full Text] [Related]
40. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients.
Brioschi A; Gramigna S; Werth E; Staub F; Ruffieux C; Bassetti C; Schluep M; Annoni JM
Eur Neurol; 2009; 62(4):243-9. PubMed ID: 19672078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
